, capture the fair compensation that we deserve. So that's how we're looking at it. And I think it's important to recognize that as we move forward. And I think we'll just â€“ we'll continue to monitor and communicate that out as we move forward in our planning process. 

In conclusion, based on the company's recent earnings call and financial guidance for 2018, we recommend an 'overweight' investment stance on the company. The strong performance in the third quarter and the outlook for fiscal 2018, despite some headwinds, demonstrate the company's ability to navigate challenges and continue to grow. With a solid customer base and opportunities for revenue growth in the healthcare environment, the company is uniquely positioned to deliver long-term value to its shareholders. The commitment to managing expenses and maximizing efficiencies, along with the potential for positive free cash flow in the coming year, further supports the recommendation for an 'overweight' investment stance.